Noorik Biopharmaceuticals


Develops precision tools to remodel the tumor microenvironment with the goal of overcoming drug resistance in cancer and improving predictable target engagement and tumor delivery of systemic therapies.

Industries

Biotechnology
Medical
Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

small (1-50)

Noorik Biopharmaceuticals

Basel, Basel-Stadt, Switzerland, Europe


Patents

Treatment of portal hypertension and cirrhosis

US-11883400-B2

View Details

Ambrisentan for use in the treatment of acute renal failure

US-11642307-B2

View Details

Ambrisentan for use in the treatment of acute renal failure

US-10870021-B2

View Details

Expertise Areas

  • Tumor microenvironment modulation
  • Oncology drug resistance research
  • Targeted drug delivery
  • Translational oncology
  • Show More (1)

Key Technologies

  • Tumor microenvironment modulation
  • Targeted drug delivery platforms
  • Target engagement assays
  • Translational oncology development

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.